Suchergebnisse - "Hildebrandt, Martin"

PubPharm (42)

1

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control : a case study

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

2

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

3

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

4

Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study

enthalten in: Strahlentherapie und Onkologie | 2019

von Kokowski, K. | Stangl, S. | Seier, S. | +3

5

Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy

enthalten in: PloS one | 2019

von Faist, B. | Schlott, F. | Stemberger, C. | +11

6

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach

enthalten in: Cancer immunology, immunotherapy : CII | 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9

7

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

enthalten in: Cancer immunology immunotherapy | 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9

8

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

enthalten in: Cancer immunology immunotherapy | 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9

9

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach

enthalten in: Cancer immunology immunotherapy | 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9

10

Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies : the German Cancer Consortium approach

enthalten in: Cancer immunology immunotherapy | 29 January 2018

von Krackhardt, A. | Anliker, B. | Hildebrandt, M. | +9

1
2
3
4
5
Nächster »
[5]